發(fā)布時(shí)間：2024-05-14
如果中度或重度三尖瓣返流未被治療，4年內(nèi)，每2人就將有1人死亡！[1]
二尖瓣手術(shù)的同時(shí)應(yīng)常規(guī)治療中度及以上三尖瓣返流或三尖瓣瓣環(huán)擴(kuò)張[2, 3]
三尖瓣成形使用硬環(huán)的療效優(yōu)于其它方式
使用硬環(huán)術(shù)后中重度三尖瓣反流復(fù)發(fā)率最低
產(chǎn)品特性
參考文獻(xiàn)
[1]Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol 2004;43:405
[2]Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) [J]. Europ Heart J, 2021. DOI :10.4244/eij-e-21-00009.
[3]Otto C M , Nishimura R A , Bonow R O , et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease[J]. Journal of Thoracic and Cardiovascular Surgery, 2021, 162(suppl E).
[4]Navia Jose L,Nowicki Edward R,Blackstone Eugene H et al. Surgical management of secondary tricuspid valve regurgitation: annulus, commissure, or leaflet procedure?[J] .J Thorac Cardiovasc Surg, 2010, 139: 1473-1482.e5.
電話：010-60735920/60735930
投資者電話：010-60735931
總部傳真：010-89700424
銷售業(yè)務(wù)專線：010-60735932
郵箱：bjbalance@balancemed.cn
采購(gòu)部郵箱：purchase@balancemed.cn
英才招聘：hr@balancemed.cn
投資者關(guān)系郵箱：ir@balancemed.cn
郵編：102200
地址：北京市昌平區(qū)科技園東區(qū)華昌路2號(hào)